Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients

Table 3 Serum vascular endothelial growth factor and tryptase levels in 71 patients with hepatocellular cancer measured 1 d prior and subsequent to treatment with trans-arterial chemoembolization

Sample collectiontime	n	Mean concentrations of serum VEGF ± SD(pg/mL)	Mean concentrations of serum tryptase ± SD (μg/L)
24 h before TACE	71	114.31 ± 79.58	8.13 ± 3.61
24 h after TACE	71	238.14 ± 109.41	4.02 ± 3.03
P value		< 0.000231	< 0.00124

VEGF: Vascular endothelial growth factor; HCC: Hepatocellular carcinoma; TACE: Trans-arterial chemoembolization; SD: Standard deviation.